(Received for publication November 30, 1996) An antifungal antibiotic, benanomicin A, binds in the presence of Ca2+ to susceptible fungi and some bacteria, but not to antibiotic-resistant bacteria and mammaliancells. With the susceptible yeast Saccharomyces cerevisiae, benanomicin A binds similarly to whole cells and to protoplasts. Studies using benanomicin A and three structurally related derivatives suggested that a carboxylic acid in the D-alanine moiety and a sugar moiety in the benanomicin A molecule are essential for both binding and antifungal activities against growing S. cerevisiae. An amino substituent on the sugar moiety can be replaced with a hydroxyl group without the loss of activities. Benanomicin A binds to various yeast mannans which differ in glycosidic linkages. These results indicate that binding of benanomicin A to the mannanportion of fungal cells is essential for exertion of the antifungal activity.
Benanomicin A produced by Actinomadura sporaxia) is a red-colored antibiotic consisting of benzo [a] naphthacenequinone, D-alanine and a disaccharide (Fig. 1) . 3) Previous studies demonstrated that benanomicin A inhibits growth of a wide range of pathogenic fungi including Candida spp., Aspergillus spp. and Gryptococcus neoformans, that parenteral doses of the antibiotic protected mice against a lethal infection with these fungi, and that it was well tolerated by mice and other experimental animals. 4' 5) At an early stage of our investigation, it was observed that a red-colored ring was formed in the marginal region of inhibitory zones on agar mediumimplanted with a test fungus when an agar diffusion assay with the antibiotic was performed. In addition, fungal cells aggregated and showed a red color when they were treated with the antibiotic in liquid medium. These findings strongly suggested that substantial amounts of benanomicin A are bound to fungal cells when the antibiotic and cells are incubated together. The present study was undertaken to get informa- APR. 1996 tion on the binding property of benanomicin A to yeast cells in order to further elucidate the mode of its antifungal action. For this purpose the benanomicin Arelated compounds benanomicin B, its methyl ester and benanomicinone ( Fig. 1) , as well as several different mannanpreparations, were used to define the molecular basis of the binding activity. Preliminary results were reported elsewhere.6'7) 
Materials and Methods

Preparation of Saccharomyces Protoplasts
The washed cells of S. cerevisiae X2180-1A were suspended in 1/1 5 m sodium phosphate buffer containing 20mMEDTA, 1 rriM mercaptoethanol and 1.2m sorbitol as an osmotic stabilizer to give a cell suspension at a concentration of 1 x 108cells/ml.
The Benanomicin A was added to an experimental cell suspension at a final drug concentration of lOOjUg/ml, and the mixture was incubated at 37°C for 30 minutes. APR. 1996 After centrifugation at 3,000rpm for 5 minutes, the supernatant was removed, and extracted with 200 jA of DMSO.The determination of bound benanomicin A in the extract was madeusing the same methodas used for experiments with microbial cells as abovementioned. minutes, the reaction mixture was passed through a column of Sephadex G-50 (15ml), and developed with water. Effluent was collected in 1-ml fractions. With each fraction, optical density at 490 nm and antifungal activity against C. albicans cells were determined.
To test the effect of Ca2+ on benanomicin A-Saccharomycesmannaninteraction, the reaction mixture containing 400^g of benanomicin A and 5mg of Saccharomyces mannanwas supplemented with 20jig of CaCl2, adjusted to a final volume of 350jal, and passed through a Sephadex column. Minimumgrowth inhibitory concentration. Decrease in number of intact protoplasts 120 minutes after addition of drug (50 /ig/ml) in YNBD-S-PBmedium. extract prebound benanomicin A. The recovery of the antibiotic was very low when extracted with acetone (1.0%), moderate with water (14.9%), AT,JV-dimethylformamide (37.3%) or 5mM EGTA(49.5%), but almost complete with DMSO (99.0%). These results suggested that the binding was not irreversible covalent bonding but reversible hydrogen bonding.
Results
Requirement of Ca2+ for Binding of Benanomicin A to Fungal Cells
Correlation of the Structure of Benanomicin A with Its Binding Ability and Antifungal Activity Table 3 shows the extent of binding of benanomicin A and related compounds to Candida and Saccharomyces cells and their protoplasts.
Benanomicins A and B bound to both whole fungal cells and their protoplasts, in parallel to the growth-inhibitory activity (against the whole cells) and lytic activity (against the protoplasts). Benanomicin A bound to the whole cells of S. cerevisiae to a greater extent than to their protoplasts, but benanomicin B, a basic analog of benanomicin A, showed comparable binding to both whole cells and protoplasts.
Analysis of the mannancontent in the whole cells and protoplasts of S. cerevisiae X2180-1A, using the acid hydrolysates of samples, revealed that mannans in the whole cells and protoplasts were 20 and 2.5 /xg/107 cells, Protoplast Lytic Activity of Benanomicin A Figure 2 shows the time-course of lysis of S. cerevisiae protoplasts when treated with 20 jug/ml of benanomicin A in YNBD-S-PB, as measured by a decrease in optical density. Concanavalin A which is known to bind to the mannanmoiety of yeast cells was used as a reference. Benanomicin Awas capable of inducing protoplast lysis, and the extent of this was further increased by the addition of 1%Tween 80. Concanavalin A, in contrast, at 1 ,000 //g/ml induced only slight protoplast lysis which was accelerated in the presence ofTween80. One percent Tween 80 alone showed no effect on the protoplast lysis. This indicated that benanomicin A, which shows the cytolytic action alone, has a different mechanism of action than concanavalin A that requires the Tween80 for lysis.
As measured by flow cytometry, the relative fluorescence intensity of S. cerevisiae protoplasts in YNB-S-PB treated with FITC-concanavalin A (1,000 jug/ml) for 30 minutes was 311, and this was decreased to 192 after We examined benanomicin A interaction with Saccharomyces mannan using a gel filtration technique with a column of Sephadex G-50. The elution pattern of an aqueous solution of benanomicin A showed a single red-colored peak (peak I) in the range of fraction 10 accompanied by a tailing (Fig. 3A) . Whena mixture of benanomicin A and yeast mannan at a weight ratio of 1 : 12 was passed through the Sephadex column, an additional red-colored peak (peak II) appeared in the range of fraction 6 (Fig. 3B) . Mannan was exclusively recovered from peak II. Fraction 10 (peak I) was active in inhibiting fungal growth, whereas fraction 6 (peak II) showed no activity at all. Whenthe mixture of benanomicin A and yeast mannan was charged to the column in the presence of 2mMCa2+, there occurred an increase in the peak II area with a concomitant decrease in the peak I area (Fig. 3C ). This indicated that benanomicin Abound to yeast mannan, and that in so doing it lost its antifungal activity.
Interaction of Benanomicin A with Chemically Modified Yeast Mannans Table 4 shows the interaction of benanomicin A with modified yeast mannans that contain different glycosidic linkages: a-1,2 and a-1,3 (1A); a- 1, 6 (1A-5) ; and jS-1,2 (P). Utilizing the changes of absorption spectrum and optical rotation, all of these chemically modified mannans when added to an aqueous solution ofbenanomicin A produced the same spectral change. The absorption In conclusion, benanomicin A binds selectively to mannan or mannan-derived polysaccharide moieties localized on the cell envelope of fungi and other susceptible microorganisms. The carboxylic acid group, the sugar moiety and the chromophoreof benanomicin A molecule are involved in the binding for which Ca2+ is essential. Although the binding to fungal cells is necessary for benanomicin A to exert an antifungal action, it remains unanswered how the antibiotic-binding becomes lethal. Current experiments are under way to determine the mechanismof this antifungal action.
